Inflammatory Response as a Prognostic Factor of Recurrence of Atrial Fibrillation After Ablation

Assessment of Course of Inflammatory Biomarkers Concentrations After Pulmonary Veins Isolation as a Prognostic Factor of Atrial Fibrillation Treatment Effectiveness (ACtIVE-AF Study)

The aim of this study is to evaluate inflammatory response as a prognostic factor of atrial fibrillation recurrency after ablation. Inflammatory response will be assessed by double measurement of C-reactive protein, fibroblast growth factor 2 (FGF2), matrix metallopeptidase 8 (MMP8) and body temperature. Dynamics of change of troponin I will be measured additionally.

After ablation each patient will be monitored with ECG telemonitoring system for 7 days.

Inclusion Criteria:

• signed consent;
• criteria for ablation of atrial fibrillation.

Exclusion Criteria:

• previous pulmonary veins isolation;
• ablation other than pulmonary veins isolation during the procedure;
• atrial fibrillation at the beginning of ablation procedure;
• usage of 'single shot' devices.